Panobinostat (Farydak)

panobinostat · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Panobinostat (Farydak), covering 2025-05-02 to 2025-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors [Phase 1]